๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Breast imaging and breast cancer prevention

โœ Scribed by Daniel B. Kopans

Publisher
John Wiley and Sons
Year
1993
Tongue
English
Weight
290 KB
Volume
53
Category
Article
ISSN
0730-2312

No coin nor oath required. For personal study only.

โœฆ Synopsis

Earlier detection of breast cancer through periodic screening is the only currently available intervention likely to reduce breast cancer-related mortality in the near term; prevention would be preferable. The alteration of proliferative changes and the assessment of intermediate endpoints may establish some interventions as more likely than others to interrupt the progression to lethal cancer. However, since not all breast cancers are fatal, the endpoint that will ultimately be accepted as proof of prevention success will be a reduction in breast cancer mortality.

Methods of detection and monitoring must be carefully tailored so that the influences of the detection techniques do not alter the prevention results.

๐Ÿ“œ SIMILAR VOLUMES

The prevention of breast cancer
The prevention of breast cancer
โœ R. S. Prichard; A. D. K. Hill; B. Dijkstra; E. W. McDermott; N. J. O'Higgins ๐Ÿ“‚ Article ๐Ÿ“… 2003 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 153 KB ๐Ÿ‘ 1 views
Hormonal approach to breast cancer preve
Hormonal approach to breast cancer prevention
โœ Irma H. Russo; Jose Russo ๐Ÿ“‚ Article ๐Ÿ“… 2000 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 70 KB ๐Ÿ‘ 2 views

Breast cancer is more frequent in nulliparous women, while its incidence is significantly reduced by full-term pregnancy. The fact that the protection conferred by pregnancy is observed in women from different countries and ethnic groups, regardless of the endogenous incidence of this malignancy, in

Moving forward with breast cancer preven
Moving forward with breast cancer prevention
โœ Wendy Y. Chen; Bernard Rosner; Graham A. Colditz ๐Ÿ“‚ Article ๐Ÿ“… 2007 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 75 KB

Despite randomized controlled trial data supporting the use of selective estrogen receptor modulators (SERMs) to reduce the incidence of breast cancer, to the authors' knowledge uptake has been limited. Similar to cardiovascular risk models, the routine use of breast cancer risk prevention models in